AInvest★★★★★3-DAY FREE

Catch pre-market movers with AI signals.

Claim Trial
logo

PRTC(Delisted)

Puretech Health·NASDAQ
--
--(--)

Puretech Health (PRTC) Financial Statements

Puretech Health (PRTC) Cash Flow Statement

During FY 2025, Puretech Health (PRTC) generated -85.13M in cash flow from operating activities, 63.29M from investing activities, and -6.33M from financing activities. Click to view the cash flow statement and track how funds are moving through the company.

Cash Flow

FY,2017
FY,2018
H1,2019
FY,2019
H1,2020
FY,2020
H1,2021
FY,2021
H1,2022
FY,2022
H1,2023
FY,2023
H1,2024
FY,2024
H1,2025
FY,2025
TTM
Start Date
Jan 1, 2017
Jan 1, 2018
Jan 1, 2019
Jan 1, 2019
Jan 1, 2020
Jan 1, 2020
Jan 1, 2021
Jan 1, 2021
Jan 1, 2022
Jan 1, 2022
Jan 1, 2023
Jan 1, 2023
Jan 1, 2024
Jan 1, 2024
Jan 1, 2025
Jan 1, 2025
--
End Date
Dec 31, 2017
Dec 31, 2018
Jun 30, 2019
Dec 31, 2019
Jun 30, 2020
Dec 31, 2020
Jun 30, 2021
Dec 31, 2021
Jun 30, 2022
Dec 31, 2022
Jun 30, 2023
Dec 31, 2023
Jun 30, 2024
Dec 31, 2024
Jun 30, 2025
Dec 31, 2025
--
Fiscal Year-End
Dec 31
Dec 31
Dec 31
Dec 31
Dec 31
Dec 31
Dec 31
Dec 31
Dec 31
Dec 31
Dec 31
Dec 31
Dec 31
Dec 31
Dec 31
Dec 31
--
Net Cash Flows from Operating Activities
-88.69M
--
-72.80M
+17.92%
-55.33M
--
-98.16M
-34.84%
-56.10M
-1.40%
-131.83M
-34.30%
-65.37M
-16.52%
-158.27M
-20.06%
-87.25M
-33.48%
-178.79M
-12.96%
-65.13M
+25.35%
-105.92M
+40.76%
-80.01M
-22.85%
-134.37M
-26.86%
-45.94M
+42.58%
-85.13M
+36.64%
-85.13M
--
Net Income
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-65.70M
--
-41.77M
--
53.51M
+181.45%
-44.60M
-6.78%
-109.74M
-305.08%
-109.74M
--
Depreciation and Amortization
2.10M
--
2.78M
+32.35%
2.86M
--
6.67M
+139.92%
3.18M
+11.34%
6.64M
-0.30%
3.65M
+14.64%
7.29M
+9.66%
4.29M
+17.71%
8.89M
+22.04%
3.06M
-28.71%
4.93M
-44.53%
1.81M
-40.74%
3.57M
-27.61%
1.69M
-6.73%
3.35M
-6.24%
3.35M
--
Stock-based Compensation
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
4.42M
--
4.65M
--
22.85M
+417.55%
4.73M
+1.83%
8.22M
-64.02%
8.22M
--
Interest Income(expense)
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-5.08M
--
1.47M
--
-4.77M
+6.01%
-6.36M
-533.45%
32.73M
+785.84%
32.73M
--
Impairment of Assets
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
1.26M
--
45.00K
--
226.00K
-82.06%
0
-100.00%
112.00K
-50.44%
112.00K
--
Change in Working Capital
2.97M
--
9.96M
+235.49%
5.65M
--
--
--
-12.20M
-316.03%
--
--
--
--
--
--
--
--
--
--
--
--
17.37M
--
-32.17M
--
-48.15M
-377.21%
-11.81M
+63.28%
-8.63M
+82.08%
-8.63M
--
Change in Deferred Revenue
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-283.00K
--
--
--
0
+100.00%
--
--
0
--
--
--
Change in Other Working Capital
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
17.65M
--
-32.17M
--
-48.15M
-372.77%
-11.81M
+63.28%
-8.63M
+82.08%
-8.63M
--
Other Non-cash Adjustments
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-63.12M
--
-14.05M
--
-161.60M
-156.03%
10.41M
+174.14%
-11.18M
+93.08%
-11.18M
--
Net Cash Flows from Investing Activities
83.68M
--
-39.65M
-147.38%
37.00M
--
63.66M
+260.57%
266.05M
+619.06%
364.48M
+472.55%
114.96M
-56.79%
197.38M
-45.85%
-6.88M
-105.99%
-107.22M
-154.32%
173.88M
+2625.93%
68.99M
+164.34%
236.51M
+36.02%
240.89M
+249.16%
29.68M
-87.45%
63.29M
-73.73%
63.29M
--
Change in PPE and Intangible Assets
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
620.00K
--
188.00K
--
244.00K
-60.65%
166.00K
-11.70%
263.00K
+7.79%
263.00K
--
Disposal of PPE and Intangible Assets
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
865.00K
--
188.00K
--
255.00K
-70.52%
166.00K
-11.70%
269.00K
+5.49%
269.00K
--
Purchase of PPE and Intangible Assets
2.17M
--
4.49M
+106.82%
9.72M
--
--
--
2.05M
-78.86%
--
--
--
--
--
--
--
--
--
--
--
--
245.00K
--
--
--
11.00K
-95.51%
--
--
6.00K
-45.45%
6.00K
--
Change in Investments
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
99.00M
--
236.32M
--
346.61M
+250.10%
29.51M
-87.51%
64.01M
-81.53%
64.01M
--
Decrease in Investments
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
277.87M
--
449.36M
--
655.56M
+135.93%
88.79M
-80.24%
148.06M
-77.41%
148.06M
--
Increase in Investments
147.20M
--
166.45M
+13.08%
41.25M
--
--
--
500.00K
-98.79%
--
--
--
--
--
--
--
--
--
--
--
--
178.86M
--
213.03M
--
308.94M
+72.73%
59.27M
-72.18%
84.05M
-72.79%
84.05M
--
Change in long-term Equity Investments
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-30.63M
--
--
--
-105.97M
-245.92%
--
--
-1.04M
+99.02%
-1.04M
--
Change in Associates and Joint Ventures
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-16.85M
--
--
--
-14.40M
+14.54%
--
--
-1.04M
+92.79%
-1.04M
--
Change in Subsidiaries
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-13.78M
--
--
--
-91.57M
-564.32%
--
--
0
+100.00%
--
--
Other Investing Activities
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0
--
0
--
0
--
0
--
49.00K
--
49.00K
--
Net Cash Flows from Financing Activities
14.70M
--
156.89M
+967.55%
33.41M
--
49.91M
-68.19%
-2.19M
-106.57%
38.87M
-22.12%
-13.71M
-525.02%
22.73M
-41.53%
-5.67M
+58.69%
-29.83M
-231.24%
91.90M
+1722.19%
78.14M
+361.98%
-39.10M
-142.55%
-16.96M
-121.70%
-3.77M
+90.35%
-6.33M
+62.68%
-6.33M
--
Dividends Paid
91.00K
--
8.00K
-91.21%
--
--
--
--
12.52M
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Change in Debt
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-3.34M
--
-1.65M
--
-3.39M
-1.68%
-1.83M
-10.86%
-3.58M
-5.45%
-3.58M
--
Repayment of long-term Debt
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
3.34M
--
1.65M
--
3.39M
+1.68%
1.83M
+10.86%
3.58M
+5.45%
3.58M
--
Change in Capital Stock
12.33M
--
152.00M
+1132.33%
32.48M
--
--
--
11.25M
-65.36%
--
--
--
--
--
--
--
--
--
--
--
--
-18.50M
--
-105.55M
--
-3.90M
+78.94%
-1.95M
+98.16%
106.00K
+102.72%
106.00K
--
Increase in Capital Stock
12.40M
--
152.03M
+1126.05%
32.48M
--
--
--
11.25M
-65.36%
--
--
--
--
--
--
--
--
--
--
--
--
1.15M
--
895.00K
--
895.00K
-22.38%
106.00K
-88.16%
106.00K
-88.16%
106.00K
--
Decrease in Capital Stock
66.00K
--
35.00K
-46.97%
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
19.65M
--
106.45M
--
4.79M
-75.62%
2.05M
-98.07%
--
--
--
--
Other Financing Activities
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
99.98M
--
68.10M
--
-9.67M
-109.67%
-1.00K
-100.00%
-2.85M
+70.47%
-2.85M
--
Effect of Foreign Exchange Rate Changes
-3.00K
--
-44.00K
-1366.67%
-82.00K
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Other Accounts Affecting Net Increase in Cash and Cash Equivalents
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
-1.00K
--
1.00K
--
--
--
--
--
Net Increase in Cash and Cash Equivalents
9.69M
--
44.40M
+358.22%
15.00M
--
15.31M
-65.52%
207.76M
+1285.34%
271.52M
+1673.60%
35.89M
-82.73%
61.83M
-77.23%
-99.80M
-378.10%
-315.84M
-610.85%
200.65M
+301.06%
41.22M
+113.05%
117.40M
-41.49%
89.56M
+117.30%
-20.04M
-117.07%
-28.17M
-131.45%
-28.17M
--
Cash and Cash Equivalents at Beginning of Period
62.96M
--
72.65M
+15.39%
117.05M
--
--
--
132.36M
+13.08%
--
--
--
--
--
--
--
--
--
--
--
--
149.87M
--
191.08M
--
191.08M
+27.50%
280.64M
+46.87%
280.64M
+46.87%
280.64M
--
Cash and Cash Equivalents at End of Period
72.65M
--
117.05M
+61.12%
132.05M
--
--
--
340.12M
+157.57%
--
--
--
--
--
--
--
--
--
--
--
--
191.08M
--
308.48M
--
280.64M
+46.87%
260.60M
-15.52%
252.47M
-10.04%
252.47M
--

You can ask Aime

No Data